SERA PROGNOSTICS, INC. Diluted Shares Outstanding (Weighted Average)
SERA PROGNOSTICS, INC. (SERA) reported Diluted Shares Outstanding (Weighted Average) of 50.48 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-12
- SERA PROGNOSTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 50.48M shares, a 2.87% increase year-over-year.
- SERA PROGNOSTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 50.26M shares, a 19.75% increase year-over-year.
- SERA PROGNOSTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 50.01M shares, a 47.31% increase year-over-year.
- SERA PROGNOSTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 49.53M shares, a 47.74% increase year-over-year.
- SERA PROGNOSTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 47.66M shares, a 43.75% increase from fiscal 2024.
- SERA PROGNOSTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 33.16M shares, a 6.27% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 31.20M shares, a 0.83% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 30.94M shares, a 106.25% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 50.48M shares 10-Q · filed 2026-08-12 | 50.37M shares 10-Q · filed 2026-08-12 | 50.25M shares derived: average of 3 quarters · filed 2026-08-12 | 50.07M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 50.26M shares 10-Q · filed 2026-05-06 | 50.13M shares derived: average of 2 quarters · filed 2026-05-06 | 49.93M shares derived: average of 3 quarters · filed 2026-05-06 | 49.71M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 50.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 49.77M shares derived: average of 2 quarters · filed 2026-03-18 | 49.53M shares derived: average of 3 quarters · filed 2026-08-12 | 47.66M shares 10-K · filed 2026-03-18 |
| 2025-09-30 | 49.53M shares 10-Q · filed 2025-11-13 | 49.30M shares derived: average of 2 quarters · filed 2026-08-12 | 46.88M shares 10-Q · filed 2025-11-13 | 43.63M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 49.07M shares 10-Q · filed 2026-08-12 | 45.54M shares 10-Q · filed 2026-08-12 | 41.66M shares derived: average of 3 quarters · filed 2026-08-12 | 39.63M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 41.97M shares 10-Q · filed 2026-05-06 | 37.96M shares derived: average of 2 quarters · filed 2026-05-06 | 36.48M shares derived: average of 3 quarters · filed 2026-05-06 | 35.59M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 33.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | 33.73M shares derived: average of 2 quarters · filed 2026-03-18 | 33.47M shares derived: average of 3 quarters · filed 2026-03-18 | 33.16M shares 10-K · filed 2026-03-18 |
| 2024-09-30 | 33.52M shares 10-Q · filed 2025-11-13 | 33.23M shares derived: average of 2 quarters · filed 2025-11-13 | 32.89M shares 10-Q · filed 2025-11-13 | 32.52M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 32.93M shares 10-Q · filed 2025-08-06 | 32.58M shares 10-Q · filed 2025-08-06 | 32.19M shares derived: average of 3 quarters · filed 2025-08-06 | 31.96M shares derived: average of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | 32.22M shares 10-Q · filed 2025-05-07 | 31.82M shares derived: average of 2 quarters · filed 2025-05-07 | 31.64M shares derived: average of 3 quarters · filed 2025-05-07 | 31.50M shares derived: average of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | 31.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | 31.35M shares derived: average of 2 quarters · filed 2025-03-19 | 31.26M shares derived: average of 3 quarters · filed 2025-03-19 | 31.20M shares 10-K · filed 2025-03-19 |
| 2023-09-30 | 31.29M shares 10-Q · filed 2024-11-06 | 31.18M shares derived: average of 2 quarters · filed 2024-11-06 | 31.13M shares 10-Q · filed 2024-11-06 | 31.10M shares derived: average of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | 31.08M shares 10-Q · filed 2024-08-07 | 31.05M shares 10-Q · filed 2024-08-07 | 31.04M shares derived: average of 3 quarters · filed 2024-08-07 | 31.03M shares derived: average of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | 31.02M shares 10-Q · filed 2024-05-08 | 31.02M shares derived: average of 2 quarters · filed 2024-05-08 | 31.01M shares derived: average of 3 quarters · filed 2024-05-08 | 31.00M shares derived: average of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | 31.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | 31.01M shares derived: average of 2 quarters · filed 2024-03-20 | 30.99M shares derived: average of 3 quarters · filed 2024-03-20 | 30.94M shares 10-K · filed 2024-03-20 |
| 2022-09-30 | 31.01M shares 10-Q · filed 2023-11-08 | 30.98M shares derived: average of 2 quarters · filed 2023-11-08 | 30.92M shares 10-Q · filed 2023-11-08 | 30.91M shares derived: average of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | 30.95M shares 10-Q · filed 2023-08-09 | 30.87M shares 10-Q · filed 2023-08-09 | 30.88M shares derived: average of 3 quarters · filed 2023-08-09 | 29.43M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 30.80M shares 10-Q · filed 2023-05-10 | 30.85M shares derived: average of 2 quarters · filed 2023-05-10 | 28.93M shares derived: average of 3 quarters · filed 2023-05-10 | 22.19M shares derived: average of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | 30.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 27.99M shares derived: average of 2 quarters · filed 2023-03-22 | 19.32M shares derived: average of 3 quarters · filed 2023-03-22 | 15.00M shares 10-K · filed 2023-03-22 |
| 2021-09-30 | 25.09M shares 10-Q · filed 2022-11-09 | 13.54M shares derived: average of 2 quarters · filed 2022-11-09 | 9.71M shares 10-Q · filed 2022-11-09 | 7.63M shares derived: average of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | 1.99M shares 10-Q · filed 2022-08-10 | 1.89M shares 10-Q · filed 2022-08-10 | 1.81M shares derived: average of 3 quarters · filed 2022-08-10 | 1.74M shares derived: average of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | 1.79M shares 10-Q · filed 2022-05-10 | 1.71M shares derived: average of 2 quarters · filed 2022-05-10 | 1.65M shares derived: average of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | 1.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 1.59M shares derived: average of 2 quarters · filed 2022-03-29 | 1.56M shares 10-K · filed 2022-03-29 | |
| 2020-09-30 | 1.54M shares 10-Q · filed 2021-11-09 | 1.53M shares 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |